- Home
- Equipment
- tajikistan
- cells for potential therapeutic
Show results for
Refine by
Cells For Potential Therapeutic Equipment & Supplies In Tajikistan
26 equipment items found
Manufactured by:Altucell, Inc. based inNew York, NEW YORK (USA)
Encapsulated cell therapy is an emerging area of biopharmaceutical research that aims to unleash the therapeutic potential of cells to treat serious diseases without the need for immunosuppression. Altucell has developed patented, proprietary engineered cells that are combined with a patented encapsulation ...
Manufactured by:Kangstem Biotech Co., Ltd. based inGangnam-gu, SOUTH KOREA
FURESTEM-AD Inj. is the world’s first stem cell therapeutic product for atopic dermatitis that targets moderate to severe atopic dermatitis ...
Manufactured by:DiscGenics, Inc. based inSalt Lake City, UTAH (USA)
DiscGenics is harnessing the restorative potential of cells native to the intervertebral disc to develop what we believe will be a profound therapeutic option for millions of patients suffering from the debilitating effects of low back ...
Manufactured by:Regeneron Pharmaceuticals Inc. based inTarrytown, NEW YORK (USA)
elociT™ is our unique mouse technology for producing fully human therapeutic T-cell receptors (TCR) against tumor and viral antigens. Regeneron uses this technology as part of its efforts to discover and develop novel immuno-oncology therapeutic candidates, including combination approaches and to assist our collaborators in producing fully human therapeutic ...
Manufactured by:Thermo Fisher Scientific based inWaltham, MASSACHUSETTS (USA)
Use the Thermo Scientific™ Nunc™ Automatic Cell Factory™ Manipulator System (ACFM), which features electronic and pneumatic controls, to automate the filling and emptying of a medium or cell suspension into 4 x 3 Nunc Cell Factory 10 systems or 4 x 1 Nunc Cell Factory 40. Specifically designed to lend innovation and efficiency for highly-effective upstream or downstream ...
Manufactured by:RoosterBio, Inc. based inFrederick, MARYLAND (USA)
cGMP xeno-free human bone marrow-derived MSCs to support allogenic therapeutic cell manufacturing. Using a comprehensive and qualified supply chain of our high volume, well-characterized, and standardized WCBs (working cell banks) for large scale cell manufacturing – you’re now able to bypass major steps in cGMP manufacturing. With a rapid 2D process and path to Phase 1 – using ...
Manufactured by:Thermo Fisher Scientific based inWaltham, MASSACHUSETTS (USA)
Use the Thermo Scientific™ Nunc™ Automatic Cell Factory™ Manipulator System (ACFM), which features electronic and pneumatic controls, to automate the filling and emptying of a medium or cell suspension into 4 x 3 Nunc Cell Factory 10 systems or 4 x 1 Nunc Cell Factory 40. Specifically designed to lend innovation and efficiency for highly-effective upstream or downstream ...
Manufactured by:Human Med AG based inSchwerin, GERMANY
The only system for harvesting regenerative cells (SVF) that can be used at the point-of-care. The new compact Q-graft system for the intraoperative separation and collection of regenerative cells (stromal vascular fraction/ SVF) from adipose tissue will support and enhance the research and clinical application of SVF cells for many therapeutic indications. Unlike other methods, the Q-graft ...
by:Zymeworks Inc based inVancouver, BRITISH COLUMBIA (CANADA)
with a modular suite of proprietary cytotoxins (cell-killing compounds), stable linkers, and conjugation technologies. A broader window of opportunity. Deliver potent cell-killing compounds specifically to diseased target cells with optimal safety and efficacy. ZymeLink™, a next-generation antibody drug conjugate (ADC) platform, is a suite of proprietary cytotoxins (cell-killing compounds), ...
Manufactured by:Cytena based inFreiburg, GERMANY
Faster than Ever Before: By automating labor-intensive and time-consuming steps, the F.SIGHT 2.0 significantly streamlines Cell Line Development (CLD), Cell & Gene therapy, as well as Single-cell Omics workflows. The F.SIGHT 2.0 is the fastest single-cell dispenser that isolates both unlabeled and green fluorescent cells. With our patented, highly efficient and gentle single-cell technology, ...
Manufactured by:Terumo Blood and Cell Technologies, Inc. based inLakewood, COLORADO (USA)
The Spectra Optia system is an industry-leading therapeutic apheresis, cell processing and cell collection platform that allows operators to spend more time focusing on patient care. This advanced system uses continuous-flow centrifugation and optical detection technology, providing operators the ability to perform a wide variety of apheresis procedures on a single ...
by:TQ Therapeutics GmbH based inPlanegg, GERMANY
TQx is developing a modular target cell-specific modification platform including relevant technology components for the generation of gene modified cell therapy ...
Manufactured by:Kangstem Biotech Co., Ltd. based inGangnam-gu, SOUTH KOREA
Kangstem Biotech is developing stem cell therapeutic products for patients suffering from rare and incurable diseases using umbilical cord blood-derived stem ...
Manufactured by:Nuclidium AG based inBasel, SWITZERLAND
Nuclidium AG leverages the unique properties of copper radionuclides to advance precision radiotherapy and diagnostics. Their proprietary CuTrace™ platform combines copper nuclides with tumor-specific molecules, creating diagnostic and therapeutic pairs designed to optimize the safety and efficacy profile in cancer treatment. These radionuclides, including 61Cu for diagnostics and 67Cu for ...
by:Vaccitech plc based inOxford, UNITED KINGDOM
The patented Vaccitech adenovirus vectors are known as chimpanzee adenovirus Oxford 1 and 2 (ChAdOx1 and ChAdOx2), and are in the group E simian adenovirus family, similar to the widely-studied chimpanzee adenovirus 63. These viruses have been engineered to be replication deficient and can be manufactured in well-established HEK293 cell lines containing the adenoviral E1 ...
Manufactured by:Pluristem Therapeutics Inc. based inHaifa, ISRAEL
PLX-R18 cells release a combination of therapeutic proteins in response to a damaged or poorly functioning hematopoietic system; this system creates the blood cells that protect us from infection, uncontrolled bleeding and anemia. PLX-R18 is currently in a Phase I clinical trial to treat incomplete hematopoietic recovery following Hematopoietic Cell Transplantation (HCT) and in development to ...
Manufactured by:The Electrospinning Company Ltd. based inDidcot, UNITED KINGDOM
Significant advances in recent years mean that cell therapy is becoming a clinical reality. The unique characteristics of electrospun materials, including scaleability, minimal immunogenicity, regulatory familiarity and the ability to create a custom product, mean that they are well suited for this exciting area of regenerative medicine. We are confident that current challenges for the next ...
Manufactured by:Eywa srl based inRimini, ITALY
The fruit of Italian research, LIMFA Therapy is a medical device for non-invasive cellular stimulation, through ultra-weak, complex and patented magneto-electric fields which, by entering into bio-resonance with cellular ions, are able to accelerate self-repair cell with an average efficacy, scientifically proven, of 80%. To get the most out of LIMFA Therapy sequences, the signal must reach the ...
Manufactured by:Celularity Inc. based inFlorham Park, NEW JERSEY (USA)
We are developing CYNK-101 as a combination treatment for multiple cancer indications. CYNK-101 is manufactured from a specific type of immune cell, NK cells, that we extract from postpartum placentas and then genetically engineer to increase cell killing activity when introduced together with an antibody-based anti-cancer treatment. ...
Manufactured by:Minaris Regenerative Medicine, LLC based inAllendale, NEW JERSEY (USA)
At Minaris Regenerative Medicine, we are committed to bringing together and further developing highly talented, skilled, and dedicated experts with varied backgrounds applicable to gene and cell therapy manufacturing and development. Having this team creates the potential to accelerate your progress to market and to both anticipate and overcome your challenges, while reducing the overall cost and ...